Johnson & Johnson (JNJ) Stock on November 25, 2025: Ex‑Dividend Day, Options Surge and a $3 Billion Cancer Bet
Date: November 25, 2025 Johnson & Johnson (NYSE: JNJ) heads into Tuesday’s session at or near record highs, riding a wave of bullish options activity, a key ex‑dividend date today and a string of growth-focused pipeline moves in cancer and